Correlation Between Oracle and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Oracle and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oracle and Novo Nordisk AS, you can compare the effects of market volatilities on Oracle and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Novo Nordisk.
Diversification Opportunities for Oracle and Novo Nordisk
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oracle and Novo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Oracle i.e., Oracle and Novo Nordisk go up and down completely randomly.
Pair Corralation between Oracle and Novo Nordisk
Given the investment horizon of 90 days Oracle is expected to under-perform the Novo Nordisk. But the stock apears to be less risky and, when comparing its historical volatility, Oracle is 1.1 times less risky than Novo Nordisk. The stock trades about -0.04 of its potential returns per unit of risk. The Novo Nordisk AS is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 8,411 in Novo Nordisk AS on December 2, 2024 and sell it today you would earn a total of 633.00 from holding Novo Nordisk AS or generate 7.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Oracle vs. Novo Nordisk AS
Performance |
Timeline |
Oracle |
Novo Nordisk AS |
Oracle and Novo Nordisk Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oracle and Novo Nordisk
The main advantage of trading using opposite Oracle and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.Oracle vs. Palo Alto Networks | Oracle vs. Crowdstrike Holdings | Oracle vs. Microsoft | Oracle vs. Adobe Systems Incorporated |
Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |